Long-Term Study for Psoriatic Arthritis
Psoriatic arthritis (PsA) is a long-lasting condition that causes inflammation in the joints and skin. This study aims to learn more about the safety and effectiveness of a treatment called zasocitinib for adults with PsA over an extended period.
Study site: NeoClinical Research
- Psoriatic arthritis (PsA)
- About the Study
- Psoriatic arthritis (PsA) is a long-lasting condition that causes inflammation in the joints and skin. This study aims to learn more about the safety and effectiveness of a treatment called zasocitinib for adults with PsA over an extended period. If you have completed a 1-year treatment in one of our earlier studies, you may be eligible to join this long-term study. Everyone in this study will take zasocitinib once a day, either at a lower or higher dose. You can be part of this study for about 2 years (108 weeks), which includes up to 2 years of treatment (104 weeks) and a 1-month follow-up to check on your health.
- What does the study involve?
- Zasocitinib oral tablets.
What to expect
- Placebo
- Everyone receives an active treatment.
- Which treatment you get
- Chosen at random. Neither you nor the study team will know which treatment you get.
- Who can participate?
- We're looking for adults aged 18 and older who have completed a 1-year treatment in one of our earlier studies. You should be able to benefit from continuing the treatment. If you think you might qualify, apply to find out!
Where is the study taking place?
Palmetto Medical Plaza
Study details
- Sponsor
- Takeda
- Phase
- Phase 3: confirming it works in a large group, often against current treatment
- Dates
- March 2026 to December 2029 (expected)
- Size
- 1182 participants across all sites
- Healthy volunteers
- Only people with the condition
Study details are from ClinicalTrials.gov. The rest of this page is written by the study site for patients and may summarize or reword the registry record, which is the official text. A study listed on ClinicalTrials.gov has not necessarily been reviewed or approved by the U.S. government.
About NeoClinical Research
NeoClinical Research is a leading, multi-therapeutic clinical research center based in South Florida that bridges the gap between leading pharmaceutical companies and diverse patient populations.